Chemotherapy for non-small-cell lung cancer.

Bibliographic Details
Published in:Lancet Vol. 358; no. 9289; pp. 1270 - 1272
Main Authors: Satoh, H, Sekizawa, K
Format: commentary Journal Article
Published: Lancet 10/13/2001
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133362645&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 133362645
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 10/13/2001
      vid: 358
      iid: 9289
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        133362645
        133362645
        NLM11675089
        133362645
        10.1016/s0140-6736(01)06362-0
        NLM11675089
        133362645
      ppf: 1270
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Chemotherapy for non-small-cell lung cancer.
      aug:
        au:
          Satoh, H
          Sekizawa, K
      sug:
        subj:
          Lung Neoplasms Drug Therapy
          Adenocarcinoma Drug Therapy
          Hydrocarbons
          Antineoplastic Agents, Combined Therapeutic Use
          Carcinoma, Non-Small-Cell Lung Drug Therapy
          Lung Neoplasms Pathology
          Prognosis
          Paclitaxel Analogs and Derivatives
          Deoxycytidine
          Paclitaxel Administration and Dosage
          Deoxycytidine Administration and Dosage
      pubtype: Academic Journal
      doctype:
        commentary
        Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N